pembrolizumab
merck
['bcsm', 'tnbc', 'pembro']
this is what we need: ability to use neoadjuvant pembro for #tnbc without "too much" chemo. pcr 58%, 2 yr dfs 89%. compares quite favorably with "less" chemo. #asco22 #bcsm 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.